Shareholder Primacy cover image

Legal and financial questions of Pfizer-Novo-Metsera

Shareholder Primacy

00:00

How Novo Returned with a Higher Upfront Cash Bid

Mike recounts Novo reoffering a more front‑loaded bid, adding indemnities to address litigation and regulatory risks.

Play episode from 16:58
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app